This application seeks support for the Immunocompromised Host Society's (ICHS) 18th International Symposium on Infections in the Immunocompromised Host. This meeting will be held in Berlin, Germany at the Langenbeck-Virchow Haus from June 15-17, 2014. The 18th symposium follows several successful symposia, the most recent ones being held in Genoa, Italy (17th Symposium, 2012) Budapest, Hungary (16th Symposium, 2010) and Thessaloniki, Greece (15th Symposium, 2008). The meeting is designed for infectious disease specialists, hematologists, oncologists, transplant physicians, microbiologists, immunologists and others with an interest in infections in the immunocompromised host. The scientific program will include key sessions on all aspects of infections in the immunocompromised patient presented by internationally renowned experts in the field. The meeting format is designed to encourage participation from young investigators and we will actively recruit those participants who are historically underrepresented by covering the cost of their travel arrangments and registration fees. The 17th symposium drew over 350 participants from over 40 countries and included over 80 abstracts. The 18th symposium promises to promote the interchange of science and medicine in the context of the latest approaches to the care of immunocompromised patients.

Public Health Relevance

The 18th International Symposium on Infections in the Immunocompromised Host is focused on the needs of the immunocompromised patient and brings together a wide variety of clinician/specialists, research scientists, and biopharmaceutical leaders to exchange recent progress and novel findings as well as to address current challenges in the field. The ICHS symposia have a long track record of attracting large numbers of international experts. Thus, the ICHS symposia greatly facilitate the interaction between researchers studying immunocompromised patients who would not normally interact, allowing novel collaborations for the treatment and management of infections in immunocompromised individuals to be discussed and disseminated to a broad, international audience.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Conference (R13)
Project #
1R13AI112239-01
Application #
8720337
Study Section
Special Emphasis Panel (ZAI1-KP-M (J2))
Program Officer
Coulter, Nancy A
Project Start
2014-03-01
Project End
2015-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
1
Fiscal Year
2014
Total Cost
$8,000
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655